S23:E2 – Mapping the Pathway in Metastatic Breast Cancer

In this episode, Mapping the Pathway in Metastatic Breast Cancer, Dr. Joyce O’Shaughnessy and Dr. Reshma Mahtani take a deeper dive into the phosphatidylinositol 3-kinase (PI3K) and AKT inhibitors for the treatment of metastatic hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer. This episode will help you better understand these treatments as well as the causes of treatment resistance. Visit https://suitehome.atpointofcare.com/library/2685.02/page/0?subdomain=breastcancer to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.